Clinical Trial Update: Safety and Tolerability of 4975 in Patients Undergoing Arthroscopic Surgery to Repair the Rotator Cuff of the Shoulder [Phase 2]

View source ↗

Summary

Phase 2 safety and tolerability study of 4975 in patients undergoing arthroscopic rotator cuff repair was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotator Cuff Tear

Drugs mentioned

• 4975

Snippet

Sponsor: Anesiva, Inc. | Conditions: Rotator Cuff Repair of the Shoulder | Phase 2 | Status: TERMINATED